<p style="margin: 0px; text-align: justify;">In a discussion on Akashvani’s Spotlight program, Professor Dr N N Mathur, Former Director, Lady Hardinge Medical College and Rajesh Lekh, Anchor talked about Preparedness of Public Health System in View of Rising Covid-19 Cases.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;">Professor Dr N N Mathur discussed about JN1 sub-variant of Omicron, its symptoms, precautions, and how worrisome is it for the common man. He said that As the world gears up for the festive season, the emergence of the JN1 subvariant of Omicron, labeled a variant of interest by the WHO, has sparked concerns. Dr. Mathur sheds light on this new strain, distinguishing it as a lineage within the Omicron family, specifically BA 2.86.1.1, a deviation from the previous XBB lineage.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;">Reassuringly, initial observations indicate its mild nature, presenting symptoms akin to a mild flu or upper respiratory tract infection’manifesting as a runny or congested nose, low-grade fever, and fatigue. Notably, unlike previous variants, JN1 hasn't exhibited a high incidence of pneumonia or severe lung complications, primarily affecting the upper respiratory system. While there have been reports of fatalities in some regions, Dr. Mathur clarifies that these cases were primarily linked to underlying health conditions rather than direct consequences of the JN1 strain. Emphasizing its relatively milder impact, he recommends cautiousness but assures the public that, thus far, it resembles a mild influenza-like illness. Vigilance and basic precautions remain essential, yet widespread alarm might be premature considering its less severe manifestation compared to earlier variants. COVID-19 isn't likely to vanish; it's now an integral part of our ecosystem, subject to continuous mutations that lead to the emergence of new variants. Dr. Mathur underscores this reality, emphasizing the perpetual coexistence with these viruses. Their genetic evolution results in varying impacts on human health’sometimes mild, occasionally posing a greater risk. Nonetheless, the trend seems to lean toward milder manifestations. Dr. Mathur stresses the importance of constant vigilance, advocating for ongoing sampling to track the virus's changes.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;">Dr. Mathur highlights that individuals who've received vaccinations are indeed protected against this prevalent strain. According to WHO, the current vaccines exhibit efficacy against JN1. Whether a specific vaccine or booster dose will be necessary is a decision pending further assessment and deliberation for future considerations.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;">Understanding the virus's mutations is like witnessing Darwin's theory in action survival of the fittest but on a microscopic level. Dr. Mathur draws parallels between human survival instincts and the virus's persistence within the ecosystem. To survive and propagate, the virus adapts by altering its form. However, detecting these changes doesn't occur through simple observation under a microscope; it requires genome sequencing.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;">Echoing the idea that viruses persist even as immunity builds and seasons shift, Dr. Mathur emphasizes the ongoing presence of these genetic elements in the population. Reassuringly, existing vaccines are effective against the new variant, eliminating the immediate need for a new vaccine. However, decisions regarding booster doses rest with the government. Addressing the common man's concerns, Dr. Mathur advocates maintaining the familiar precautions of mask-wearing, social distancing, and avoiding crowded places. Symptoms of the JN1 variant align with mild influenza, prompting individuals to undergo RT-PCR tests if such symptoms arise. This not only confirms potential COVID-19 infection but also provides samples for genome sequencing by specialized labs like INSACOG (NIV Pune and NCDC). These laboratories continually update WHO on the virus's genetic changes, and crucial information guiding responses and strategies.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;">The analogy between the virus's adaptive behavior and human survival instincts paints a vivid picture of the ongoing struggle between pathogens and our immune systems. Dr. Mathur's explanation demystifies the necessity for genome sequencing to track the virus's evolutionary path. He elucidates the role of specialized labs in monitoring genetic changes, underscoring the importance of these findings in shaping global health strategies. Moreover, his clarification about symptoms and the significance of RT-PCR tests empowers individuals to take proactive steps in confirming and managing potential infections, offering a semblance of control in an evolving scenario.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;">Dr. Mathur delves into complexities surrounding the JN1 sub-lineage of BA2.86, highlighting its detection in several countries with active genomic surveillance. Addressing the misconception about the virus's behavior in extreme temperatures, he clarifies that there's no direct correlation between the virus's activity and temperature variations. Reflecting on previous surges, he dismisses the notion that cold weather suppresses the virus, emphasizing that transmission occurs due to proximity and confined spaces rather than seasonal changes.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;">In discussions about booster doses, Dr. Mathur concedes that logically, booster doses could be considered, especially with the fading of antibody levels in previously immunized individuals. However, he contemplates a future where periodic vaccines akin to flu shots might become necessary to combat evolving variants like Omicron, contemplating a vaccination regimen possibly required every year or two, adapting to the virus's changing nature.</p>”<p style="margin: 0px; text-align: justify;"> </p>”<p style="margin: 0px; text-align: justify;"><span style="color: #222222;">Reflecting on the practical implications for daily life, Dr. Mathur advises cautiousness, particularly during the initial phase of a variant's emergence. He recommends continuing sensible precautions such as social distancing, mask-wearing, and maintaining distance, especially during the upcoming holiday season and the initial period of the new variant's evolution. This cautious approach aims to navigate the evolving landscape of the virus while allowing individuals to resume normalcy with sensible measures in place.</span></p>
News On AIR | December 22, 2023 9:40 PM | Akashvani's Spotlight program | Former Director | Lady Hardinge Medical College | Professor Dr N N Mathur
Discussion on Akashvani programe ‘Spotlight’ about Preparedness of Public Health System in View of Rising Covid-19 Cases